Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 6/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | OGFRL1 | Q5TC84 | 12/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.45 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3525096 | 0.85 | CCR5 (0.49) | CCR5CHRM2CHRM1CHRM3OGFRL1 | |
| SCHEMBL3525310 | 0.84 | CCR5 (0.55) | CCR5OGFRL1OPRM1OPRK1OPRD1 | |
| SCHEMBL3525459 | 0.84 | CCR5 (0.49) | CCR5CHRM2CHRM1CHRM3OGFRL1 | |
| SCHEMBL13543532 | 0.83 | CCR5 (0.49) | CCR5CHRM2CHRM1CHRM3OGFRL1 | |
| SCHEMBL3525118 | 0.81 | CCR5 (0.51) | CCR5CHRM2CHRM1CHRM3OGFRL1 | |
| SCHEMBL6158050 | 0.78 | CCR5 (0.44) | CCR5CHRM2CHRM1CHRM3OGFRL1 | |
| SCHEMBL853681 | 0.77 | OGFRL1 (0.69) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL21548005 | 0.77 | OGFRL1 (0.69) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL852176 | 0.77 | OGFRL1 (0.69) | OGFRL1OPRM1OPRK1OPRD1OPRL1 | |
| SCHEMBL880517 | 0.77 | OGFRL1 (0.69) | OGFRL1OPRM1OPRK1OPRD1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7645771-B2 | CCR5 antagonists as therapeutic agents | SMITHKLINE BEECHAM CORP. (US) | 2010-01-12 | — | — | US | disclosed |
| US-7645771-B2 | CCR5 antagonists as therapeutic agents | SMITHKLINE BEECHAM CORP. (US) | 2010-01-12 | — | — | US | disclosed |